1. R.O. Casasnovas (France) C. Chang (USA) B. Chiu (USA) A. Delmer (France) K. Ekstrom Smedby (Sweden) P. Gaulard (France) T. Lamy de la Chapelle (France) V. Leblond (France) S. Le Gouill (France) M. Maynadié (France) A. Monnereau (France) L. Morton (USA) N. Rothman (USA) G. Salles (France) S. Slager (USA) X. Troussard (France) C. Vajdic (Australia) A. van den Berg (Netherlands) S. Wang (USA) Comité Scientifique Scientific Committee Access to the Faculty of Medicine 7 boulevard Jeanne d'Arc - Dijon Joint meeting 2013 InterLymph Symposium 2 e Journée d’Epidémiologie des Hémopathies Malignes Lymphoma aetiology and prognosis, the role of environment and genetic susceptibility June 24- 26, 2013 Dijon, France Airport Dijon-Bourgogne Regular flights from Bordeaux, Toulouse, Nantes, Nevers… Train - Tramway From the Railway station Dijon Ville : take Line1 to "Quetigny", stop at "CHU-Hôpitaux". Car When arrivieng in Dijon, follow « DIJON Université ». Taxi Dijon Taxi, call center : 03 80 41 41 12 Partenaires

2. 2013 InterLymph Symposium 2 e Journée d’Epidémiologie des Hémopathies Malignes Lymphoma aetiology and prognosis, the role of environment and genetic susceptibility 9:00 Registration 9:45 Welcome (M Maynadié) 10:00-11:30 Latest findings from the InterLymph Consortium [chairs : S Wang – X Troussard] 10:00-10:20 Comparison of risk factors for all subtypes (L Morton) 10:20-10:40 Key risk factors for rarer B-cell subtypes (A Monnereau/P Bracci) 10:40-11:00 Genome-wide association study (GWAS) of non-Hodgkin lymphoma subtypes : an overview (N Rothman) 11:00-11:20Interaction between autoimmune disease and immune polymorphisms in risk of non-Hodgkin lymphoma (S Wang) 11:20-11:30 Discussion 11:30-12:00 Coffee break / Morning tea / Poster session 12:00-01:30 Lymphoma and Survival [chairs : K Ekstrom-Smedby – T Lamy] 12:00-12:20 Survival of lymphoma in Europe (M Sant) 12:20-12:40 Lifestyle factors and non-Hodgkin lymphoma survival (A Seniori) 12:40-01:00 Prognostic Factors in Lymphoma: Can observational epidemiology studies get the same answers as RCTs? (J Cerhan) 01:00-01:20 Germline genetic variation and lymphoma outcomes (H Ghesquieres) 01:20-01:30 Discussion 01:30-02:20 Lunch 02:20-03:00 Hodgkin Lymphoma [chairs : S Slager - RO Casasnovas] 02:20-02:40 Risk factors for Classical Hodgkin lymphoma (H Hjalgrim) 02:40-03:00 Meta analysis of the GWAS strategy in Hodgkin lymphoma (W Cozen) 03:00-03:20 Defining a Predictive Blood Biomarker for Follicular Lymphoma (B Nadel) 03:20-03:30 Discussion 03:30-04:00 Coffee break / Afternoon tea / Poster session 04:00-05:30 Round table: Second cancer in lymphoid malignancies [chairs : L. Morton – G Salles] 04:00-04:20 K2-France Project (J Jégu) 04:20-04:40 K2-France: second cancer in Follicular Lymphoma and in DLBCL (C Rossi) 04:40-05:00 Second cancer in Follicular Lymphoma included in clinical trials (C Thieblemont) 05:00-05:20 K2-France: second cancer in CLL (X Troussard) 05:20-05:30 Discussion 05:30 Wrap-up (M Maynadié) 7:30-8:00 On-site Registration 8:00-10:00 Pathology /Survival working group meeting Subtypes Initiative 10:00-10:30 Coffee break / Morning tea 10:30-012:30 Immunology and Infection working group 12:30-02:00 Lunch Group photo 02:00-04:00 Lifestyle and Environment working group 04:00-04:30 Coffee break/Afternoon tea 04:30-06:30GWAS Initiative 06:30Dinner 8:00-9:40 Hodgkin Lymphoma Working Group 9:40-10:00 Coffee break / Morning tea 10:00-12:00 Hodgkin Lymphoma Working Group 12:00-01:00Working Lunch INTERLYMPH Business meeting 01:00-02:00 Family studies working group 02:00-03:00 International Multiple Myeloma Consortium 03:00-03:20 Coffee break/Afternoon tea 03:20-06:00 International Multiple Myeloma Consortium June 24, 2013June 25, 2013June 26, 2013